Ann: Appendix 4C - quarterly , page-3

it is quite alot to look back over that has been underway over the first quarter of 2011 - certainly it appears alot has been happening & incoming revenue has come very close to expenditre over the period, it is encouraging to see the company is certainly not sitting still...

so for $178k cash burn look at what has been achieved -


** Mediimune / AstraZeneca - screening ongoing

** Pfizer - screening ongoing

** PYC / XL-Protein - pilot study

** PYC / Isogenica - Proof of concept completed on tech. compatability

** Proof of concept completed on TBI candidate

** Succesfull completion of objectives in intial Roche stage

** Phenomica spin-off put in motion

** US intracellular screening patent granted

** Share Placement negotiated

** ongoing negotiations with major pharmaceutical companies

** presentations ongoing - JP Morgan (NY) - BioTrinity (UK) etc.


So hows the next 9 months going to play out ? :-) :-)